伴与不伴REM睡眠行为障碍的抑郁症肠道微生物组特征
该研究采用四组病例对照设计(N=420),比较健康对照、单纯抑郁症、抑郁症合并REM睡眠行为障碍(RBD)及特发性RBD的肠道微生物组。结果发现抑郁症合并RBD表现出前驱神经退行性特征,其微生物组成和功能更接近特发性RBD,随机森林模型可区分老年抑郁症合并RBD与单纯抑郁症。
要点
- 抑郁症合并RBD患者表现出前驱帕金森病样特征,包括嗅觉减退和轻微运动体征。
- 抑郁症合并RBD的肠道微生物组组成与特发性RBD相似,而与单纯抑郁症不同。
- 随机森林模型区分老年抑郁症合并RBD与单纯抑郁症的AUC在交叉验证中为0.73,验证数据集中为0.79。
核心结论
- 抑郁症合并RBD可能代表一种与潜在神经退行性风险相关的生物学独特抑郁症亚型。
- 肠道微生物组为精神疾病人群的风险分层提供了候选方法。
研究设计与样本
- 四组病例对照设计,共420名参与者:健康对照124例、单纯抑郁症80例、抑郁症合并RBD 82例、无精神疾病特发性RBD 134例。
- 所有参与者接受临床评估并提供粪便样本进行宏基因组测序,使用随机森林模型区分抑郁症合并RBD。
- 验证数据集包含65名参与者:抑郁症合并RBD 31例和单纯抑郁症34例。
主要发现
- 抑郁症合并RBD表现出前驱神经退行性特征,包括前驱帕金森病总似然比升高、嗅觉缺陷和轻微运动体征。
- 抑郁症合并RBD的微生物组成不同于健康对照和单纯抑郁症,而与特发性RBD相似。
- 在分类学上,抑郁症合并RBD表现出类似特发性RBD的菌群失调(如Akkermansia muciniphila、Ruthenibacterium lactatiformans富集;Faecalibacterium prausnitzii耗竭),同时伴有抑郁症相关变化(如Streptococcus parasanguinis和Actinomyces oris)。
- 在功能上,抑郁症合并RBD表现出B族维生素生物合成和多糖降解能力减弱,与特发性RBD相似。
- 随机森林机器学习模型区分老年抑郁症合并RBD与单纯抑郁症的AUC在交叉验证中为0.73,在验证数据集中为0.79。
临床怎么用
- 对抑郁症患者应评估RBD特征,以识别可能具有神经退行性风险的前驱亚型。
- 肠道微生物组特征可作为精神疾病人群风险分层的候选生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Major depressive disorder (MDD) is a risk factor for neurodegeneration, yet its heterogeneity makes identifying at-risk subtype challenging. Notably, MDD frequently co-occurs with REM sleep behavior disorder (RBD), a specific prodrome of α-synucleinopathy. It remains unclear whether comorbid MDD + RBD reflects a benign antidepressant effect, or higher neurodegenerative risk. Given growing recognition of gut-brain axis in neuropsychiatry, we aimed to delineate microbial signatures of MDD + RBD. We employed a four-group case-control design (N = 420) comprising 124 healthy controls (HC); 80 MDD without RBD features (MDD-only); 82 MDD + RBD; and 134 iRBD without psychiatric disease. All participants underwent clinical evaluation and provided fecal samples for metagenomic sequencing. Random Forest model was used to distinguish MDD + RBD, and further assessed in a validation dataset of 65 participants with MDD + RBD (n = 31) and MDD-only (n = 34). MDD + RBD exhibited prodromal neurodegenerative features, including elevated total likelihood ratio of prodromal Parkinson's Disease, olfactory deficits, and subtle motor signs. The microbial composition in MDD + RBD differed from HC and MDD-only, while resembling iRBD. Taxonomically, MDD + RBD exhibited an iRBD-like dysbiosis (e.g., enriched Akkermansia muciniphila, Ruthenibacterium lactatiformans; depleted Faecalibacterium prausnitzii), alongside depression-associated shifts (e.g., Streptococcus parasanguinis and Actinomyces oris). Functionally, MDD + RBD showed attenuated capacity of B‑vitamin biosynthesis and polysaccharides degradation, mirroring iRBD. The Random Forest machine-learning model distinguished MDD + RBD in older adults from MDD-only with an AUC of 0.73 in cross-validation and 0.79 in the validation dataset. MDD + RBD may represent a biologically distinct depression subtype associated with potential neurodegenerative risk. Gut microbiome provides a candidate approach for potential risk stratification in psychiatric populations.
引用
- Yang Y, Li N, Zhou L, et al. Gut Microbiome in Depression with and without REM Sleep Behavior Disorder. Mol Psychiatry. 2026. PMID: 42493609. doi:10.1038/s41380-026-03773-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。